Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 10Completed 6Enrolling by invitation 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 73Gastrointestinal 8Genitourinary 7Thoracic 5Gynecologic 4Dermatologic 3Sarcoma 2NET 2Lymphoid 2Endocrine 2Other solid neoplasm 1Other hematologic neoplasm 1Other 1Head & Neck 1CNS 1

Conditions

Neuroendocrine Tumors 5Carcinoma, Neuroendocrine 2Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Melanoma 1Lymphoma 1Gastro-enteropancreatic neuroendocrine tumor 1Disease Progression 1Carcinoma 1Carcinoid Tumor 1Adenoma, Islet Cell 1Adenocarcinoma 1

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Breast Neoplasms × NET × Clear all
NCT05160480 2026-03-10

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

University of California, Davis

Enrolling by invitation
9 enrolled
BreastEndocrineGenitourinaryNET

Breast Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors

NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Enrolling by invitation
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡